TXMD trade ideas
TXMD Downtrend-Internal ReboundTo keep it simple: the March crash brought around a strong consolidation in a triangle pattern within the lower segment (channel 3) of the longer-term, down-trending channel that the stock has stuck to for over five years now. Looks like it will jump upwards in early July.
Previous larger drops on the decline have passed the support and gone into channel 4 here (bouncing back over time), yet even with the scale of the March crash, TXMD hasn't gotten to that point. Still steadily holding towards the middle (channel 2) once again.
TXMD going to next MAIt should go up to the next Moving Average. Big gain possible.
I will try to jump in on monday morning :)
TXMD - Long - Perfect Trading Zones All,
I actually think .70 - .95 is actually a solid buy in here.
Stop loss around 10% under just in case
Purple = targets.. I think think first 3 should be no problem, but just in case. The top two are unlikely .. at least quickly.
$TXMD Lowering wedge here, watch for break out.Needs to pop above this lowering wedge, a pop above could push it to fill gap.
TXMD - BREAK OUT. CAN IT CARRY ON THE TREND. 15% MINIMUM MOVETherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
SHORT INTEREST
84.93M 07/15/19
P/E Current
-3.83
P/E Ratio (with extraordinary items)
-3.21
Average Recommendation: BUY
Average Target Price: 10.57
$TXMD TherapeuticsMD.inc no cure in sight for longs.Not really a household name among investors but well known to the ever growing of shorts. As of March 26th there was a 38% short interest. Despite FDA approval for 3 new drugs sales have been dismal and the company has increased expenditure on sales to tackle the issue, thus driving operating expenses much higher. The price currently sits at $4.57 well below the analysts average target of $15 which is hard to explain. Like any stock in the drug manufacturing sector the price can spike very quickly, so if your shorting keep stop losses very tight.
Long Set Up
A long set up with a good profit to loss ratio.
Stock has previously broken the 200 EMA. Appears to be starting a full-on uptrend.
Best of luck.
TXMD Opportunity for a major run coming into 2019Inside on the support line of a Bullish Symmetrical Triangle, with 3 FDA approved drugs about to hit the market with massive revenues.
TXMD FDA Approval Annovera (birth control)i see strong up movment coming
join my friends channel for education
contingenttrader.com
TXMDFDA Announcement for Tuesday 5/29/18 can see a nice pop past resistances and peak between $8 - $11.50 with correct volume. Short squeeze will be the first step in order to achieve this goal.
NASDAQ/NGS:TXMDMight want to be on your watch list in the morning for a potential chart. Comment if you'd like.
